Suppr超能文献

肥胖与心血管疾病:美国心脏协会科学声明

Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association.

出版信息

Circulation. 2021 May 25;143(21):e984-e1010. doi: 10.1161/CIR.0000000000000973. Epub 2021 Apr 22.

Abstract

The global obesity epidemic is well established, with increases in obesity prevalence for most countries since the 1980s. Obesity contributes directly to incident cardiovascular risk factors, including dyslipidemia, type 2 diabetes, hypertension, and sleep disorders. Obesity also leads to the development of cardiovascular disease and cardiovascular disease mortality independently of other cardiovascular risk factors. More recent data highlight abdominal obesity, as determined by waist circumference, as a cardiovascular disease risk marker that is independent of body mass index. There have also been significant advances in imaging modalities for characterizing body composition, including visceral adiposity. Studies that quantify fat depots, including ectopic fat, support excess visceral adiposity as an independent indicator of poor cardiovascular outcomes. Lifestyle modification and subsequent weight loss improve both metabolic syndrome and associated systemic inflammation and endothelial dysfunction. However, clinical trials of medical weight loss have not demonstrated a reduction in coronary artery disease rates. In contrast, prospective studies comparing patients undergoing bariatric surgery with nonsurgical patients with obesity have shown reduced coronary artery disease risk with surgery. In this statement, we summarize the impact of obesity on the diagnosis, clinical management, and outcomes of atherosclerotic cardiovascular disease, heart failure, and arrhythmias, especially sudden cardiac death and atrial fibrillation. In particular, we examine the influence of obesity on noninvasive and invasive diagnostic procedures for coronary artery disease. Moreover, we review the impact of obesity on cardiac function and outcomes related to heart failure with reduced and preserved ejection fraction. Finally, we describe the effects of lifestyle and surgical weight loss interventions on outcomes related to coronary artery disease, heart failure, and atrial fibrillation.

摘要

全球肥胖症流行已经得到充分证实,自 20 世纪 80 年代以来,大多数国家的肥胖症患病率都有所增加。肥胖症直接导致心血管风险因素的发生,包括血脂异常、2 型糖尿病、高血压和睡眠障碍。肥胖症还会导致心血管疾病的发生和心血管疾病死亡率的增加,而与其他心血管风险因素无关。最近的数据强调了腰围确定的腹部肥胖作为一种独立于体重指数的心血管疾病风险标志物。在描述身体成分的成像方式方面也取得了重大进展,包括内脏脂肪。定量脂肪储存(包括异位脂肪)的研究支持过多的内脏脂肪是不良心血管结局的独立指标。生活方式的改变和随后的体重减轻可以改善代谢综合征以及相关的全身炎症和内皮功能障碍。然而,医学减肥的临床试验并没有显示出冠心病发病率的降低。相比之下,将接受减肥手术的患者与肥胖的非手术患者进行比较的前瞻性研究表明,手术可以降低冠心病的风险。在本声明中,我们总结了肥胖症对动脉粥样硬化性心血管疾病、心力衰竭和心律失常(尤其是心源性猝死和心房颤动)的诊断、临床管理和结局的影响。特别是,我们检查了肥胖症对冠心病非侵入性和侵入性诊断程序的影响。此外,我们回顾了肥胖症对射血分数降低和保留的心衰相关心功能和结局的影响。最后,我们描述了生活方式和手术减肥干预对冠心病、心力衰竭和心房颤动相关结局的影响。

相似文献

1
Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association.
Circulation. 2021 May 25;143(21):e984-e1010. doi: 10.1161/CIR.0000000000000973. Epub 2021 Apr 22.
2
Interventions for weight reduction in obesity to improve survival in women with endometrial cancer.
Cochrane Database Syst Rev. 2023 Mar 27;3(3):CD012513. doi: 10.1002/14651858.CD012513.pub3.
4
Active body surface warming systems for preventing complications caused by inadvertent perioperative hypothermia in adults.
Cochrane Database Syst Rev. 2016 Apr 21;4(4):CD009016. doi: 10.1002/14651858.CD009016.pub2.
5
Interventions for weight reduction in obesity to improve survival in women with endometrial cancer.
Cochrane Database Syst Rev. 2018 Feb 1;2(2):CD012513. doi: 10.1002/14651858.CD012513.pub2.
6
Gut microbiome-based interventions for the management of obesity in children and adolescents aged up to 19 years.
Cochrane Database Syst Rev. 2025 Jul 10;7(7):CD015875. doi: 10.1002/14651858.CD015875.
8
Music for stress and anxiety reduction in coronary heart disease patients.
Cochrane Database Syst Rev. 2013 Dec 28;2013(12):CD006577. doi: 10.1002/14651858.CD006577.pub3.
9
Effects of a gluten-reduced or gluten-free diet for the primary prevention of cardiovascular disease.
Cochrane Database Syst Rev. 2022 Feb 24;2(2):CD013556. doi: 10.1002/14651858.CD013556.pub2.
10
Antidepressants for pain management in adults with chronic pain: a network meta-analysis.
Health Technol Assess. 2024 Oct;28(62):1-155. doi: 10.3310/MKRT2948.

引用本文的文献

2
Black Cumin Seed () Confers Anti-Adipogenic Effects in 3T3-L1 Cellular Model and Lipid-Lowering Properties in Human Subjects.
Food Sci Nutr. 2025 Sep 1;13(9):e70888. doi: 10.1002/fsn3.70888. eCollection 2025 Sep.
3
Application of Honey from as a Sugar Substitute to Design Functional Cookies for Controlling Carbohydrate Digestion.
Prev Nutr Food Sci. 2025 Aug 31;30(4):391-398. doi: 10.3746/pnf.2025.30.4.391.
4
Lipid overload meets S-palmitoylation: a metabolic signalling nexus driving cardiovascular and heart disease.
Cell Commun Signal. 2025 Sep 2;23(1):392. doi: 10.1186/s12964-025-02398-3.
5
Peer Coaching to Support Weight Management in Primary Care: A Cluster Randomized Clinical Trial.
JAMA Netw Open. 2025 Sep 2;8(9):e2529136. doi: 10.1001/jamanetworkopen.2025.29136.
7
Circular RNAs in Metabolic Diseases.
Adv Exp Med Biol. 2025;1485:349-368. doi: 10.1007/978-981-96-9428-0_20.
9
Center Stage: Putting Obesity Staging Systems Into the Spotlight.
Prev Chronic Dis. 2025 Aug 28;22:E55. doi: 10.5888/pcd22.250222.
10
Trends in the global burden of aortic valve calcification disease in the working-age population from 1992 to 2021.
Front Cardiovasc Med. 2025 Aug 12;12:1544273. doi: 10.3389/fcvm.2025.1544273. eCollection 2025.

本文引用的文献

1
Weight Stigmatization and Binge Eating in Asian Americans with Overweight and Obesity.
Int J Environ Res Public Health. 2020 Jun 17;17(12):4319. doi: 10.3390/ijerph17124319.
3
Treatment of Obesity in Mitigating Metabolic Risk.
Circ Res. 2020 May 22;126(11):1646-1665. doi: 10.1161/CIRCRESAHA.119.315897. Epub 2020 May 21.
5
Obesity Treatment Among Adolescents: A Review of Current Evidence and Future Directions.
JAMA Pediatr. 2020 Jun 1;174(6):609-617. doi: 10.1001/jamapediatrics.2020.0085.
7
Sodium Glucose Co-transporter 2 Inhibitors and Heart Failure.
Am J Cardiol. 2019 Dec 1;124(11):1790-1796. doi: 10.1016/j.amjcard.2019.08.038. Epub 2019 Sep 10.
8
Association of Cardiovascular Disease With Premature Mortality in the United States.
JAMA Cardiol. 2019 Dec 1;4(12):1230-1238. doi: 10.1001/jamacardio.2019.3891.
9
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction.
N Engl J Med. 2019 Nov 21;381(21):1995-2008. doi: 10.1056/NEJMoa1911303. Epub 2019 Sep 19.
10
Lean Mass Abnormalities in Heart Failure: The Role of Sarcopenia, Sarcopenic Obesity, and Cachexia.
Curr Probl Cardiol. 2020 Nov;45(11):100417. doi: 10.1016/j.cpcardiol.2019.03.006. Epub 2019 Mar 28.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验